Kombiglyze XR saxagliptin/metformin regulatory update

FDA approved an NDA from Bristol-Myers and AstraZeneca for Kombiglyze XR to treat Type II diabetes. Kombiglyze is a fixed-dose combination of once-daily Onglyza saxagliptin and extended-release metfo...